Coronavirus

Last Modified:

The latest news and announcements from Emory University and Emory Healthcare about coronavirus.

On October 11, 2021, Merck and Ridgeback announced submission of EUA application to FDA for Molnupiravir.

Media Contacts

Janet Christenbury
404-727-8599 
jmchris@emory.edu

Jill Wu
404-727-3870 
jill.s.wu@emory.edu 

Story Hub photo

Featured Stories »

molnupiravir

United Kingdom becomes first country to approve Emory-discovered drug for COVID-19

An Emory-invented antiviral treatment for COVID-19 has been authorized by British regulators, making molnupiravir the first antiviral pill approved for use against SARS-CoV-2. An emergency use application is also under consideration by the U.S. Food and Drug Administration.

Emory experts available to discuss COVID-19

Emory experts available to discuss COVID-19

Emory has a number of faculty members and health care professionals who can speak about many facets of the COVID-19 outbreak.

Molnupiravir pills

EUA application submitted for COVID-19 antiviral discovered at Emory

Molnupiravir, an investigational oral antiviral drug discovered by Emory researchers, appears to significantly reduce the risk of hospitalization or death in patients with mild to moderate COVID-19, according to interim data from a Phase 3 study.

Jodie Guest and Alex Truong, professors at Emory University

COVID-19 Q&A: 'What is long COVID?'

Emory pulmonologist Alex Truong joins epidemiologist Jodie Guest to answer questions about long COVID, including who is at risk and what symptoms people may experience.

woman receiving vaccination

Emory experts available to answer questions on FDA approval of COVID-19 vaccines

The U.S. Food and Drug Administration (FDA) has approved Pfizer-BioNTech’s COVID-19 vaccine. Emory experts are available to discuss the FDA approval announcement as well as all the other ways COVID-19 continues to impact us all.

Screen shot of Facebook Live event

What full FDA approval of Pfizer’s vaccine means for the future of the pandemic

In a conversation recorded Aug. 24, 2021, Emory infectious disease experts Aneesh Mehta and Colleen Kelley answer questions about FDA approval COVID-19 vaccines, virus variants, masking and more.

Vaccination

Emory research contributions built path to COVID-19 vaccine

Emory researchers have been involved in testing all three of the COVID-19 vaccines currently in use in the United States, along with others that may play important roles in the future.

COVID virus

COVID-19 survivors may possess wide-ranging resistance to the disease

Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.

George Painter, PhD, CEO of Emory's DRIVE

Antiviral drug invented by Emory’s DRIVE licensed in India for COVID-19 emergency

To address the intensifying COVID-19 crisis in India, the pharmaceutical company Merck has agreed to facilitate the manufacture and distribution of molnupiravir, an investigational antiviral drug that was discovered at Emory.

Virus

How two SARS-CoV-2 variants affect antibodies from vaccines

A more contagious coronavirus variant known as B.1.1.7 is still susceptible to antibodies induced after COVID-19 infection or vaccination. But another called B.1.351 modestly reduces antibodies' potency.

Map of the United States

New Georgia COVID-19 data adds important local dimension to national tracking tool

Emory University researchers have enhanced their dynamic national COVID-19 Health Equity Dashboard to provide more localized information on the impact of the pandemic in communities across Georgia.

George Painter

Drug launched at Emory reduces virus that causes COVID-19 to undetectable levels

An antiviral drug initially discovered by Emory’s non-profit drug development company DRIVE appears safe and reduces SARS-CoV-2 to undetectable levels in COVID-19 patients after five days of administration, according to data from a Phase II clinical trial.

More News »

Symposium celebrates Emory graduate students' contributions to COVID-19 response

Nov. 23, 2021

COVID-19 Q&A: Travel and holiday safety

Nov. 23, 2021

COVID-19 Q&A: Where are we now?

Nov. 18, 2021

Emory students help Atlanta communities have ‘Faith in the Vaccine’

Nov. 16, 2021

COVID-19 Q&A: What you need to know about vaccines for kids

Nov. 11, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

Nov. 9, 2021

Emory joins new national coalition to improve patient care and address unmet medical needs

Nov. 9, 2021

Emory launches study to understand long COVID-19 as part of a nationwide initiative

Nov. 4, 2021

United Kingdom becomes first country to approve Emory-discovered drug for COVID-19

Nov. 4, 2021

Symposium to highlight Emory graduate students’ contributions to COVID-19 response

Nov. 3, 2021

COVID-19 Q&A: Children’s health during COVID-19

Nov. 2, 2021

Emory supports Medicines Patent Pool and Merck license agreement for molnupiravir to treat COVID-19

Oct. 27, 2021

Emory physician answers questions about new CDC booster recommendations

Oct. 26, 2021

From boosters to vaccine hesitancy, a biostatistician weighs in on the data

Oct. 21, 2021

Emory president discusses research excellence and molnupiravir discovery

Oct. 18, 2021

Answering questions about pregnancy and COVID-19

Oct. 12, 2021

COVID-19 Q&A: 'What is long COVID?'

Oct. 12, 2021

Answering your questions about CDC booster recommendations

Oct. 7, 2021

EUA application submitted for COVID-19 antiviral discovered at Emory

Oct. 1, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

Sep. 21, 2021

Pfizer says COVID-19 vaccine safe, spurs immune response in kids ages 5 to 11

Sep. 21, 2021

Explaining COVID-19 breakthrough infections

Sep. 21, 2021

The difference between COVID-19 ‘third doses’ and ‘boosters’

Sep. 10, 2021

Emory partners with Atlanta mayor’s office to provide COVID-19 vaccines in Piedmont Park

Sep. 9, 2021

With FDA approval of Pfizer COVID-19 vaccine, vaccinations remain top of mind for metro Atlanta health care systems

Aug. 26, 2021

What full FDA approval of Pfizer’s vaccine means for the future of the pandemic

Aug. 26, 2021

Emory research contributions built path to COVID-19 vaccine

Aug. 26, 2021

Emory experts available to answer questions on FDA approval of COVID-19 vaccines

Aug. 23, 2021

Baricitinib, first tested at Emory against COVID-19, emerges as major treatment option

Aug. 10, 2021

Emory to require faculty and staff COVID-19 vaccinations for fall 2021

July 27, 2021

COVID-19 survivors may possess wide-ranging resistance to the disease

July 22, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

July 20, 2021

COVID-19 vaccine antibodies weaker vs. Delta/Kappa viral variants

July 13, 2021

‘Emory Inspired’: Emory mobilizes COVID-19 vaccinations

July 6, 2021

The way forward: Bridging the divide

July 6, 2021

MOMI-Vax study evaluates COVID-19 vaccination during pregnancy and postpartum

July 6, 2021

The way forward: Rebounding from a wrecked economy

June 29, 2021

Emory University researchers awarded NIH grant to conduct COVID-19 surveillance through detection of SARS Coronavirus-2 in wastewater

June 24, 2021

The way forward: Sparking educational evolution

June 21, 2021

Emory testing 'mix and match' booster shots for COVID-19 vaccines

June 15, 2021

The way forward: Preparing for the next pandemic

June 14, 2021

Emory joins COVID-19 College Challenge, part of White House ‘National Month of Action’

June 3, 2021

President Fenves announces updates to Emory's COVID-19 protocols

June 3, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

May 25, 2021

Through Council on Competitiveness, Emory takes role in increasing American innovation

May 20, 2021

A ‘heart’ for health, justice and helping others

May 7, 2021

Emory, Children’s Healthcare of Atlanta launch COVID-19 vaccine trial for young children

May 7, 2021

Emory testing next-generation COVID-19 vaccines

May 5, 2021

‘Batgirl’ takes on new discoveries in disease ecology, rabies transmission

April 27, 2021

Antiviral drug invented by Emory’s DRIVE licensed in India for COVID-19 emergency

April 27, 2021

COVID-19 Community Update: Immunization required for Emory students in fall

April 22, 2021

Emory to require student COVID-19 vaccinations for fall 2021

April 19, 2021

New Georgia COVID-19 data adds important local dimension to national tracking tool

April 14, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

April 13, 2021

April 8 COVID-19 Community Update: Progression to “yellow” status

April 8, 2021

Emory part of consortium developing model of care plan for future pandemics

April 6, 2021

Emory senior helps develop COVID-19 Health Equity Dashboard

April 5, 2021

Emory participating in Moderna COVID-19 variant vaccine study

April 1, 2021

Emory Healthcare administers 100,000 doses of COVID-19 vaccine

March 25, 2021

COVID-19 experiment finds promising government strategies for community engagement

March 25, 2021

March 24 COVID-19 Community Update: Expanded vaccine eligibility

March 24, 2021

How two SARS-CoV-2 variants affect antibodies from vaccines

March 22, 2021

Drug launched at Emory reduces virus that causes COVID-19 to undetectable levels

March 17, 2021

Transfer of COVID-19 antibodies from pregnant women to newborns lower than expected

March 15, 2021

Study shows community exposure as greatest risk of COVID-19 infection in health care workers, not health care setting

March 11, 2021

Emory epidemiologist braves Alaskan tundra for COVID-19 testing at Iditarod

March 11, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

March 11, 2021

COVID-19: One year later

March 10, 2021

'Fighting for my family'

March 9, 2021

March 9 COVID-19 Community Update: Changes to Georgia’s vaccine distribution plan and Emory’s response

March 9, 2021

COVID-19 antibody study: 1/8 in USA infected by October 2020

March 8, 2021

Vote for Emory in STAT Madness and give COVID-19 a one-two punch!

March 1, 2021

Feb. 24 COVID-19 Community Update: How Emory is helping lead vaccine efforts

Feb. 24, 2021

International study finds increased COVID-19 mortality among adults with Down syndrome

Feb. 22, 2021

Emory, Curry College researchers examine role of COVID-19 antibodies on reinfection

Feb. 19, 2021

Rouphael appointed Hope Clinic executive director

Feb. 15, 2021

NIH grant funds Emory work on indoor air sensor for SARS-CoV-2

Feb. 15, 2021

Emory and Georgia Tech students join forces to ‘Hack COVID-19’

Feb. 10, 2021

Emory launches new vaccination tracker as part of its online health equity dashboard

Feb. 10, 2021

Feb. 9 COVID-19 Community Update: Vaccines and variants

Feb. 9, 2021

Healing our 'two traumas'

Feb. 9, 2021

COVID-19 missteps could be used to help strengthen science and public health, experts say

Feb. 9, 2021

SARS-CoV-2 variants: CDC, private foundations support genomic surveillance

Feb. 5, 2021

Emory expanding post-COVID clinics for 'long haulers'

Feb. 5, 2021

Emory-developed COVID-19 vaccine safe, effective in animal models

Feb. 4, 2021

Atlanta Falcons invite local health care heroes to attend Super Bowl LV

Feb. 3, 2021

COVID-19 Community Update: Feb. 3, 2021

Feb. 3, 2021

Community exposure, Black race help predict health care worker risk for positive COVID-19 antibody tests

Feb. 2, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

Jan. 25, 2021

Virtual town hall highlights COVID-19 vaccine news

Jan. 25, 2021

Presidential inauguration features boy who played trumpet to inspire health care workers

Jan. 20, 2021

WHO, Emory experts discuss COVID-19 challenges in Facebook Live event

Jan. 14, 2021

Just another common cold virus? Modeling SARS-CoV-2’s future fade

Jan. 12, 2021

Emory ranks 5th among U.S. universities for infectious diseases program

Jan. 12, 2021

Emory begins Phase 3 study of Novavax COVID-19 vaccine

Dec. 29, 2020

Emory Healthcare administers first COVID-19 vaccinations to its frontline health care workers

Dec. 17, 2020

Emory University hosts COVID-19 vaccine town hall

Dec. 17, 2020

2020 in review: Photos from the pandemic

Dec. 16, 2020

Our stories of resilience and resolve

Dec. 15, 2020

Baricitinib speeds COVID-19 recovery in NIAID trial

Dec. 14, 2020

COVID-19 vaccine rollout demands 'unprecedented' level of communication with U.S. public

Dec. 10, 2020

Free COVID-19 test offered as part of Emory research study

Dec. 9, 2020

Valuing 'natural capital' vital to avoid next pandemic, global experts warn

Dec. 1, 2020

Emory Healthcare joins major health systems across U.S. in #MaskUp campaign

Nov. 20, 2020

Vaccine tested at Emory highly effective in preventing COVID-19, study says

Nov. 17, 2020

Warp Speed chief visits Emory, urges participation in COVID vaccine trials

Nov. 13, 2020

EmoryTogether Fund now accepting applications

Nov. 6, 2020

Research roundup: Recent grants and publications for Emory faculty and staff

Oct. 29, 2020

Emory Community Compact: Meet students and staff helping Emory beat COVID-19

Oct. 15, 2020

Emory student receives fellowship grant for humanities work

Oct. 6, 2020

Learn how Emory Libraries found creative solutions during the pandemic

Oct. 1, 2020

Emory's Center for the Study of Human Health hosts author Q&A series

Sep. 17, 2020

Help slow the spread of COVID-19 'For You. For Us. For Emory.'

Aug. 27, 2020

Emory experts to discuss COVID-19 health concerns among minorities

Aug. 25, 2020

Video: Coronavirus and Emory

Feb. 18, 2020